Les nouvelles thérapies systémiques en oncologie

Translated title of the contribution: New systemic therapies in oncology

Khalil Zaman*, Nicolas Ketterer, Diane Vulliémoz, Roger Stupp, Serge Leyvraz

*Corresponding author for this work

Research output: Contribution to journalReview article

Abstract

These last decades showed important progress in cancer systemic therapies. A better understanding of the differences between cancer cells and normal cells lead to the emergence of targeted therapies. These treatments interfere with different specific molecules playing a critical role in tumour growth or progression. On the other side, thanks to the development of new therapeutic substances, new modes of administration and to the improvement of supportive care, conventional chemotherapy is more effective and less toxic. The following review summarizes current progress with clinical impact observed these last years.

Translated title of the contributionNew systemic therapies in oncology
Original languageFrench
Pages (from-to)1361-1365
Number of pages5
JournalRevue Medicale Suisse
Volume1
Issue number20
StatePublished - May 18 2005

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'New systemic therapies in oncology'. Together they form a unique fingerprint.

  • Cite this

    Zaman, K., Ketterer, N., Vulliémoz, D., Stupp, R., & Leyvraz, S. (2005). Les nouvelles thérapies systémiques en oncologie. Revue Medicale Suisse, 1(20), 1361-1365.